MDFA’s Low Vision report highlights the evidence base supporting the benefits of aids and technologies for those with vision loss and blindness.
People living in rural and remote areas needing sight-saving treatment will benefit from an important procedural change.
The celebration of 15 years of serving the macular disease community was a reoccurring theme MDFA’s 2016 AGM.
Grand finalist and category winners of the mEYE World Photographic Competition 2016 announced to mark World Diabetes Day.
MDFA welcomes news that Ozurdex will be listed on the Pharmaceutical Benefits Scheme (PBS) from November 2016.
A National Eye Health Survey has identified that the prevalence of blindness and vision impairment in Australia has declined.
Jean Kittson lives with an increased risk of age-related macular degeneration. She’s also the carer for her elderly parents, who both have vision loss.
Erin has Stargardt’s disease, a rare genetic eye disease that generally first appears between the ages of 10 to 20.